Pro- and anti-inflammatory responses are regulated simultaneously from the first moments of septic shock

European Cytokine Network

Volumn 22, Issue 2, 2011, Pages 82-87

  Tamayo, Eduardo ^a   Fernández, Ana ^a   Almansa, Raquel ^a   Carrasco, Elena ^a   Heredia, María ^a   Lajo, Carmen ^a   Goncalves, Lisbeth ^a   Gómez Herreras, Jose I ^a   de Lejarazu, Raúl Ortiz ^a   Bermejo Martin, Jesus F ^a,b  

^a HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^b Grupo Cooperativo de Investigación Biomédica en Inmunología CIBI   (Spain)

Author keywords

Anti inflammatory; Pro inflammatory; Septic; Shock; Simultaneous

Indexed keywords

C REACTIVE PROTEIN; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROCALCITONIN;

AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATION; MALE; MEDIATOR RELEASE; SEPTIC SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

AGED; AGED, 80 AND OVER; CYTOKINES; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SHOCK, SEPTIC; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79961015817     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: 10.1684/ecn.2011.0281     Document Type: Article

References (20)

1. Schramm GE, Kashyap R, Mullon JJ, Gajic O, Afessa B.Septic shock: A Multidisciplinary response team and weekly feedback to clinicians improve the process of care and mortality. Crit Care Med 2011; 39: 252.
2. Muenzer JT, Davis CG, Chang K, et al. Characterization and modulation of the immunosuppressive phase of sepsis. Infect Immun 2010; 78: 1582.
3. Adib-Conquy M, Cavaillon JM. Compensatory anti-inflammatory response syndrome. Thromb Haemost 2009; 101: 36-47.
4. Cavaillon JM, Adib-Conquy M, Cloëz-Tayarani I, Fitting C. Immunodepression in sepsis and SIRS assessed by ex vivo cytokine production is not a generalized phenomenon: a review. J Endotoxin Res 2001; 7: 85.
5. Bozza FA, Salluh JI, Japiassu AM, et al. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care 2007; 11: R49.
6. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. 1992. Chest 2009; 136: e28.
7. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818.
8. Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/ failure On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22: 707.
9. Joachimiak MP, Weisman JL, May B. JColorGrid: software for the visualization of biological measurements. BMC Bioinformatics 2006; 7: 225.
10. Okazaki Y, Matsukawa A. Pathophysiology of sepsis and recent patents on the diagnosis, treatment and prophylaxis for sepsis. Recent Pat Inflamm Allergy Drug Discov 2009; 3: 26.
11. Pierrakos C, Vincent JL. Sepsis biomarkers: a review. Crit Care 2010; 14: R15.
12. Jager A, Kuchroo VK. Effector and regulatory T-cell subsets in autoimmunity and tissue inflammation. Scand J Immunol 2010; 72: 173.
13. Abe R, Hirasawa H, Oda S, et al. Up-regulation of interleukin-10 mRNA expression in peripheral leukocytes predicts poor outcome and diminished human leukocyte antigen-DR expression on monocytes in septic patients. J Surg Res 2008; 147: 1.
14. Mera S, Tatulescu D, Cismaru C, et al. Multiplex cytokine profiling in patients with sepsis. APMIS 2011; 119: 155.
15. Cavaillon JM, Adib-Conquy M, Fitting C, Adrie C, Payen D. Cytokine cascade in sepsis. Scand J Infect Dis 2003; 35: 535.
16. Allen ML, Hoschtitzky JA, Peters MJ, et al. Interleukin-10 and its role in clinical immunoparalysis following pediatric cardiac surgery. Crit Care Med 2006; 34: 2658.
17. Nguyen HB, Loomba M, Yang JJ, et al. Early lactate clearance is associated with biomarkers of inflammation, coagulation, apoptosis, organ dysfunction and mortality in severe sepsis and septic shock. J Inflamm (Lond) 2010; 28: 6.
18. de Pablo R, Monserrat J, Reyes E, et al. Mortality in Patients With Septic Shock Correlates With Anti-Inflammatory But not Proinflammatory Immunomodulatory Molecules. J Intensive Care Med 2011; 26: 125-32.
19. Rodríguez-Gaspar M, Santolaria F, Jarque-López A, et al. Prognostic value of cytokines in SIRS general medical patients. Cytokine 2001; 15: 232.
20. Lesur O, Roussy JF, Chagnon F, et al. Proven infection-related sepsis induces a differential stress response early after ICU admission. Crit Care 2010; 14: R131.